Live Breaking News & Updates on Sumanta Kumar Pal

Stay updated with breaking news from Sumanta kumar pal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DFF332 Elicits Efficacy and Is Safe in Advanced Clear Cell RCC

The small molecule inhibitor DFF332 elicited clinical activity and had a tolerable safety profile in patients with advanced clear cell renal cell carcinoma. ....

United States , Sumanta Kumar Pal , Bladder Cancer Disease Team , Kidney Cancer Program , Database Consortium , International Metastatic , Medical Oncology , Therapeutics Research , Hope Comprehensive Cancer Center ,

Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma

Sumanta Kumar Pal, MD, FASCO, discusses key biomarker analyses in renal cell carcinoma that will be presented at the 2024 ASCO Annual Meeting. ....

Sumanta Kumar Pal , Kidney Cancer Program , Therapeutics Research , Department Of Medical Oncology , Bladder Cancer Disease Team , Medical Oncology ,